Coverage
-
May 15, 2017
The former CEO of InterMune asked a Ninth Circuit panel Monday to revive his request that a California federal judge reverse his 2009 wire fraud conviction, claiming his attorneys never presented biostatistical expert testimony that could have cleared him of allegations he made false statements about the effectiveness of a lung disease drug.
3 other articles on this case.
View all »